Form D · Other Health Care

NeuroFine Corp.

Miramar, FL · CIK 0001888692

Offering snapshot reported Apr 8, 2026 · SEC filing

Reported sold
$1.05M
Offering amount: $1.05M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 23, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 8, 2026Initial$1,045,859No comparison14SEC filing
Sep 3, 2025Initial$125,000No comparison2SEC filing
Mar 20, 2025Initial$885,970No comparison12SEC filing
Sep 13, 2023Initial$709,651No comparison16SEC filing
Oct 20, 2021Initial$1,624,048No comparison38SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-579451
Amounts include conversion of outstanding convertible securities.

Source: Form D, filed Apr 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc Litzenberg Director
John Mc Eleney Director
Bernie Navarro Executive
Daniel Sablyak Director
Ajay Wakhloo Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
10370 Usa Today Way
Miramar, FL, 33025